Digimed Updates
  • Home
  • SAHI Updates
  • News
  • Conference
    • ADA 2025
    • HFAI 2025
    • ATTD 2024
    • ADA 2024
    • ENDO 2022
    • ESH 2022
    • ADA 2022
    • AACE 2022
    • EASD-2021
    • HFSA-2021
    • ESC-2021
    • ADA 2021
    • ACC-2021
    • ESH-ISH-2021
    • ADA 2020
    • RSSDI 2020
    • ACC-2020
    • IDF-2019
    • EASD-2019
    • ESH-2019
    • ADA-2019
    • RSSDI-2018
    • EASD-2018
  • Specialties
    • Cardiology
    • Endocrinology
    • Conference Update
    • Other Specialties Conference
  • Subscribe
  • Contact
Select Page
Factors Influencing Subclinical Atherosclerosis in Patients with Biopsy-Proven Non-alcoholic Fatty Liver Disease

Factors Influencing Subclinical Atherosclerosis in Patients with Biopsy-Proven Non-alcoholic Fatty Liver Disease

Nonalcoholic fatty liver disease (NAFLD) is a major chronic liver disease, with a worldwide prevalence of approximately 25%.

Biglycan and Atherosclerosis: Lessons from High Cardiovascular Risk Conditions

Biglycan and Atherosclerosis: Lessons from High Cardiovascular Risk Conditions

Atherosclerosis (ATH) and ATH-related diseases represent the leading cause of disability and mortality in the Western world.

Recent Guidelines for Hypertension – A Clarion Call for Blood Pressure Control in India

Recent Guidelines for Hypertension – A Clarion Call for Blood Pressure Control in India

It is estimated that nearly 1.5 billion adults in the world will have hypertension in the decade ahead.

Management of patients with ventricular arrhythmias and prevention of sudden cardiac death – translating guidelines into practice: results of the European Heart Rhythm Association survey

Management of patients with ventricular arrhythmias and prevention of sudden cardiac death – translating guidelines into practice: results of the European Heart Rhythm Association survey

The European Society of Cardiology (ESC) guidelines on the management of ventricular arrhythmias and prevention on SCD published in 2015 considered the new insights of the natural history of diseases predisposing to SCD.

Ivabradine Improves Cardiac Function and Increases Exercise Capacity in Patients with Chronic Heart Failure A Systematic Review and Meta-Analysis

Ivabradine Improves Cardiac Function and Increases Exercise Capacity in Patients with Chronic Heart Failure A Systematic Review and Meta-Analysis

Chronic heart failure (CHF) has become a global epidemic in the 21st century with considerable effects on a patient’s quality of life and a tremendous burden to healthcare systems.

« Older Entries
Next Entries »
« Previous 1 … 82 83 84 85 Next »
  • Home
  • News
  • Conference
  • Subscribe
  • Contact
The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider.
© 2021 Digimed India. All rights reserved.
  • Home
  • News
  • Conference
  • Subscribe
  • Contact
  • Facebook
  • Twitter
  • Google
  • Instagram
  • RSS

Designed by Elegant Themes | Powered by WordPress